Medical Information
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.
Not a healthcare professional? Go to the patient or caregiver website.

DOXORUBICIN Principal Display Panel (doxorubicin hydrochloride)

PRINCIPAL DISPLAY PANEL - 10 mg/5 mL Vial Label

NDC 0069-3030-20

Rx only

Single-Dose
Discard unused portion

DOXOrubicin
HCl Injection, USP

10 mg/5 mL
(2 mg/mL)

For Intravenous Use Only

Caution: Cytotoxic Agent

PRINCIPAL DISPLAY PANEL - 10 mg/5 mL Vial Label

PRINCIPAL DISPLAY PANEL - 10 mg/5 mL Vial Carton

NDC 0069-3030-20
Rx only

SINGLE-DOSE: DISCARD UNUSED PORTION

DOXOrubicin
HCl Injection,
USP

10 mg/5 mL
(2 mg/mL)

For Intravenous Use Only

Cytosafe® Vial

Caution: Cytotoxic Agent

Pfizer Injectables

PRINCIPAL DISPLAY PANEL - 10 mg/5 mL Vial Carton

PRINCIPAL DISPLAY PANEL - 20 mg/10 mL Vial Label

NDC 0069-3031-20

Rx only

Single-Dose
Discard unused portion

DOXOrubicin
HCl Injection, USP

20 mg/10 mL
(2 mg/mL)

For Intravenous Use Only

Caution: Cytotoxic Agent

PRINCIPAL DISPLAY PANEL - 20 mg/10 mL Vial Label

PRINCIPAL DISPLAY PANEL - 20 mg/10 mL Vial Carton

NDC 0069-3031-20
Rx only

SINGLE-DOSE: DISCARD UNUSED PORTION

DOXOrubicin
HCl Injection,
USP

20 mg/10 mL
(2 mg/mL)

For Intravenous Use Only

Cytosafe® Vial

Caution: Cytotoxic Agent

Pfizer Injectables

PRINCIPAL DISPLAY PANEL - 20 mg/10 mL Vial Carton

PRINCIPAL DISPLAY PANEL - 50 mg/25 mL Vial Label

NDC 0069-3032-20

Rx only

Single-Dose
Discard unused portion

DOXOrubicin
HCl Injection, USP

50 mg/25 mL
(2 mg/mL)

For Intravenous Use Only

Caution: Cytotoxic Agent

PRINCIPAL DISPLAY PANEL - 50 mg/25 mL Vial Label

PRINCIPAL DISPLAY PANEL - 50 mg/25 mL Vial Carton

NDC 0069-3032-20
Rx only

SINGLE-DOSE: DISCARD UNUSED PORTION

DOXOrubicin
HCl Injection,
USP

50 mg/25 mL
(2 mg/mL)

For Intravenous Use Only

Cytosafe® Vial

Caution: Cytotoxic Agent

Pfizer Injectables

PRINCIPAL DISPLAY PANEL - 50 mg/25 mL Vial Carton

PRINCIPAL DISPLAY PANEL - 150 mg/75 mL Vial Label

NDC 0069-3033-20

Multiple Dose Vial
Rx only

DOXOrubicin
HCl Injection, USP

150 mg/75 mL
(2 mg/mL)

For Intravenous Use Only

Caution: Cytotoxic Agent

Pfizer Injectables

PRINCIPAL DISPLAY PANEL - 150 mg/75 mL Vial Label

PRINCIPAL DISPLAY PANEL - 150 mg/75 mL Vial Carton

NDC 0069-3033-20
Rx only

Multiple Dose Vial

DOXOrubicin
HCl Injection,
USP

150 mg/75 mL
(2 mg/mL)

For Intravenous Use Only

Cytosafe® Vial

Caution: Cytotoxic Agent

Pfizer Injectables

PRINCIPAL DISPLAY PANEL - 150 mg/75 mL Vial Carton

PRINCIPAL DISPLAY PANEL - 200 mg/100 mL Vial Label

NDC 0069-3034-20

Multiple Dose Vial
Rx only

DOXOrubicin
HCl Injection, USP

200 mg/100 mL
(2 mg/mL)

For Intravenous Use Only

Caution: Cytotoxic Agent

Pfizer Injectables

PRINCIPAL DISPLAY PANEL - 200 mg/100 mL Vial Label

PRINCIPAL DISPLAY PANEL - 200 mg/100 mL Vial Carton

NDC 0069-3034-20
Rx only

Multiple Dose Vial

DOXOrubicin
HCl Injection,
USP

200 mg/100 mL
(2 mg/mL)

For Intravenous Use Only

Cytosafe® Vial

Caution: Cytotoxic Agent

Pfizer Injectables

PRINCIPAL DISPLAY PANEL - 200 mg/100 mL Vial Carton
Did you find an answer to your question? Yes No
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.

*Contact Medical Information. 9AM-5PM ET Monday to Friday; excluding holidays.

*9AM-5PM ET Monday to Friday; excluding holidays.

Submit a medical question for Pfizer prescription products.

Report Adverse Event

Contact Pfizer Safety to report an adverse event, side effect or concern about the quality of a Pfizer product: (800) 438-1985

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns at 1-800-FDA-1088 or www.fda.gov/MedWatch